Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
Artemis II astronauts make long-distance call to the space station as they head home from the moon- Benedict Cumberbatch takes on something even Sherlock can’t solve: male grief
- The Eastern Bongo, Kenya’s Rare Forest Antelope on the Brink
- How many ships have been attacked in the Gulf since start of Iran war?
- How effective is the flu shot this year? New report shows promising results
- How did I get my own unique set of fingerprints?
- Flourishing in Retirement: Individual Accounts of Post-Profession Satisfaction
- NASA astronauts take new moonsuit for a swim | Space photo of the day for Nov. 28, 2025
- AstraZeneca to acquire Modella AI to speed oncology drug research
